+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
From
Pulmonary Arterial Hypertension - Epidemiology Forecast - 2034 - Product Thumbnail Image

Pulmonary Arterial Hypertension - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 125 Pages
  • Global
From
Dilated Cardiomyopathy (DCM) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Dilated Cardiomyopathy (DCM) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 80 Pages
  • Global
From
Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Hypertension - Pipeline Insight, 2024

  • Drug Pipelines
  • December 2024
  • 240 Pages
  • Global
From
Atherosclerosis - Pipeline Insight, 2024 - Product Thumbnail Image

Atherosclerosis - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
From
Ischemic Stroke - Pipeline Insight, 2024 - Product Thumbnail Image

Ischemic Stroke - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 180 Pages
  • Global
From
Peripheral Arterial Disease (PAD)- Pipeline Insight, 2024 - Product Thumbnail Image

Peripheral Arterial Disease (PAD)- Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
From
Atrial Fibrillation - Pipeline Insight, 2024 - Product Thumbnail Image

Atrial Fibrillation - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Vascular Anomalies - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular Anomalies - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 60 Pages
  • Global
From
Myocardial Infarction - Pipeline Insight, 2024 - Product Thumbnail Image

Myocardial Infarction - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 180 Pages
  • Global
From
From
Wegener Vasculitis - Pipeline Insight, 2024 - Product Thumbnail Image

Wegener Vasculitis - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more